Solutions in 2021: adapting to a new normal
In unprecedented times, clients are struggling to build well-diversified portfolios, as well as grappling with the rising cost of guarantees and management of very expensive liabilities. After depending on fixed income diversification for decades, they must find new ways to hedge their exposures while growing assets.
Seeking out good alpha opportunities in emerging market debt
The steady recovery of the asset class has been remarkable, while the semi-mature state of EMD markets creates good alpha opportunities across sovereigns and corporates in both hard and local currencies.
European equities – the peak of pessimism is behind us
The world is going to change in 2021! We will have had Brexit, there will be a new president in the White House, and Covid-19 vaccines will be in roll-out.
2021: gotta have faith – in low discount rates
It’s been a tumultuous 2020, but the year ahead will be different and we are positioning ourselves to get the best risk-adjusted returns over the next 12-18 months.
Market Monitor – 18 December 2020
Global stock markets hit record highs this week as optimism about new stimulus measures in the US and a potentially happy outcome to Brexit negotiations in Europe brought some pre-Christmas cheer. In both cases, however, it remains to be seen whether agreements can be reached before politicians in Washington, London and Brussels take their end-of-year break: but investors appear willing to believe there are strong grounds for hope.
UK equities: resurrection of the deplorable asset class!
The UK equity market has again been out of favour, but the arrival of three vaccines, the prospect of Brexit closure and shares trading at a massive discount provide the best opportunities for a decade
Market Monitor – 8 January 2021
The Covid-19 pandemic and the way governments and businesses around the world responded to it was the root cause of practically every major stock market movement in 2020.
